Navigation Links
Mayo Researchers Say ECG Standards Should Be Revised for Elderly
Date:3/14/2008

ROCHESTER, Minn., March 14 /PRNewswire-USNewswire/ -- Researchers at Mayo Clinic suggest that the established "normal" ranges for evaluating electrocardiograms for persons over 80 years old should be "revisited." The recommendation comes in a study published today in the American Journal of Geriatric Cardiology.

After analyzing readings from more than 700 patients 80 or older, the researchers discovered that the average cutoffs (beginning and end points) for measuring all three ECG intervals -- PR, QRS and QT -- were greater than the current established norms. The findings also showed that the intervals, while greater in general, were significantly higher in men. The intervals refer to the times between recorded peaks of the specific motions in a heartbeat as represented on an electrocardiogram.

"What is normal for a population of middle-aged individuals may not be the same for the steadily increasing elderly population in this country," says Latha Stead, M.D., lead author of the study and chair of the Division of Emergency Medicine Research at Mayo Clinic.

Significance of the Findings

America's "boomer" generation is quickly aging into a geriatric generation. In 1994 one person in eight was elderly; by 2030, that figure will be one in five. As these individuals age, physicians need to have appropriate standards to evaluate their cardiac health, whether they have a routine checkup or appear in an emergency department. Mayo is seeking the best information about how to treat each individual, no matter what the age.

Researchers studied ECG results from 702 patients who came to Mayo Clinic for routine annual examinations. Forty-six percent, or 331, were men. Just under 18 percent of all patients had a history of cardiac disease. Basing their reference ranges on the healthy subgroup -- 578 patients who either had no history of heart disease or who were taking heart medication -- the researchers established average
'/>"/>

SOURCE Mayo Clinic Public Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mayo researchers say ECG standards should be revised for elderly
2. Researchers confirm link between common cold and ear infection
3. Researchers make case for standardized analysis of cardiac imaging
4. Researchers find cause of severe allergic reaction to cancer drug
5. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
6. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
7. Researchers ID behavioral risk factors for head and neck cancers
8. Red-light cameras increase crashes, researchers find
9. Leading researchers honored for progress in cancer prevention, detection and treatment
10. University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein
11. UCF researchers discover a new protein family implicated in inflammatory diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ndia's biggest drugmaker Ranbaxy Laboratories Ltd ...ply agreement with Janssen-Ortho Inc (JOI) for a g...n the Canadian market. // The agreement was signe...diary, Ranbaxy Pharmaceuticals Canada Inc (RPCI) a...
...nternational experts from the worlds of academia, ... next month to discuss how state-of-the-art// comm...le and affordable. E-health is an emerging field...rvices and information such as electronic medical ...
...orway has granted $80 million to the National Rura...ion, child and maternal health programmes.// The ...he two programme partners - for specific activitie...a and Norway also launched a multi-partner initiat...
...iming at empowering transgenders and those affecte...) was launched here today. // 'Tai Vizhuthugal' (...ther hundreds of transgenders from Coimbatore, Mad... an aim at empowering and enabling the community t...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2
(Date:8/15/2008)...ewswire/ -- Globus Medical, Inc., the largest,priv...d, today announced,that the first FLEXUS(TM) Inter...tigational Device Exemption ("IDE") recently grant...t Murray., The FLEXUS(TM) Spacer is placed with a... with minimal disruption to the surrounding muscul...
(Date:8/14/2008)... Continuing Education Activity, VOORHEES, N.J., A...significant cause of morbidity and mortality in re...n. The clinical manifestations of CMV disease are,... life-threatening,pneumonia, myelosuppression, ret...V infection and reduce CMV drug resistance, it is,...
(Date:8/14/2008)...dy (BiTE) showing clinical benefit in cancer,patie...recognize and attack ...FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a b...tary,antibodies for the treatment of cancer, infla...ublication of a Phase 1 clinical study(1) on its,B...
(Date:8/14/2008)...gy Evaluated to Enable Targeting and Increase ... LEXINGTON, Mass. and HEIDELBERG, Germany, Aug. 1...mics Research Institute (TGen) today announced,the...valuate,Next-Generation-Sequencing equipment in co...array Technology., febit,s HybSelect(TM) Technolo...
Breaking Medicine Technology:First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Large scale community protein annotation WikiProteins 5653 1Large scale community protein annotation WikiProteins 5653 2NC State breakthrough results in super hard nanocrystalline iron that can take the heat 5649 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 3WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10 2008 5646 1WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10 2008 5646 2
...ung and Colorectal Cancers, ROCKVILLE, Md., April ..., a clinical-stage pharmaceutical company developi...flammatory diseases,announced the presentation of...pounds. The data were presented by EntreMed scient...ch (AACR) Annual,Meeting in Los Angeles, Californi...
...16, 2007 - Introgen Therapeutics,Inc. (NASDAQ:ING...,the weekend in Los Angeles, California at the Ann... Research., Abnormality of the p53 tumor suppresso...lar defects in cancer. ADVEXIN,s,mechanism of acti...unction and the detection of abnormal p53 is a log...
Other Medicine Technology:EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 2EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
...ally read, qualitative immunochromatographic metho...a bacterium that grows in the stomach and is assoc...ancers. FlexSure HP, available for use with either...ian with the opportunity to perform "on-the-spot" ...
OraQuick is an FDA approved rapid point-of-care fingerstick and venipuncture whole blood test used to aid in the diagnosis of HIV-1 infection. This CLIA waived test, which detects the presence of ant
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test
...Mononucleosis test is designed to detect the IgM h...ood. The QuickVue+ Infectious Mononucleosis assay ...ive a greater sensitivity and specificity than sim...ocytes. QuickVue+ Infectious Mononucleosis is a ra...
Medicine Products: